Against all reasonable evidence, FDA then expanded that authorization in May 2021 to younger adolescents (ages 12–15), and on Nov. 2, the Centers for Disease Control and Prevention (CDC) signed off on Pfizer’s vaccine for children 5 to 11 years old.